Stay updated on INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page.

Latest updates to the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page
- ChecktodayChange DetectedThe study status is updated to Completed. Enrollment is 35 participants across 11 locations, with a primary completion date of 2025-05-09.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check29 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

- Check36 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated to v3.0.2 and Back to Top removed. No changes to core content, pricing, stock, or time slots.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has updated the facility name and location details, specifically mentioning St. Louis, Missouri, while also introducing a new version revision. However, several key terms and resources related to genetic diseases and specific medications have been removed.SummaryDifference3%

Stay in the know with updates to INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page.